MiRNA-based Lifespan extension therapy: MiRNA-208 inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 16/May/2015, 10.38 am

MiRNA-based Lifespan extension therapy: MiRNA-208 inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 16/May/2015, 10.38 am

MiRNA-based Lifespan extension therapy: MiRNA-208 inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 16/May/2015, 10.38 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., MiRNA-based Lifespan extension therapy: MiRNA-208 inhibits senescence and  extends life span by down regulating the expression of  adenylate cyclase 5 (ADCY5), 16/May/2015, 10.38 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that MiRNA-208 may extend the lifespan of an individual by suppressing the expression of ADCY5/AC5. Thus, pharmacological formulations encompassing MiRNA-208 activators” may be used to extend the life-span of an an individual.

Undisclosed information: How MiRNA-208 suppresses the expression of  adenylate cyclase 5 (ADCY5)